Understanding the Causes of Amyotrophic Lateral Sclerosis
Author:
- Richard W. OrrellRORichard W. Orrell
- 23 August 2007
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 357 (8) , 822-823
Abstract
Amyotrophic lateral sclerosis (ALS) is a human disease resulting from the degeneration of motor neurons in the brain, spinal cord, and peripheral nervous system. The resultant clinical features include weakness of the arms, legs, and face and difficulties with speech, swallowing, and breathing. ALS affects women and men, regardless of ancestry, and the risk of disease increases with age. Its clinical progression is one of the fastest of the neurodegenerative diseases, with death (often from respiratory failure) typically occurring within 3 to 5 years after onset. The incidence is approximately 2 per 100,000 persons per year, and the prevalence is . . .Keywords
This publication has 7 references indexed in Scilit:
- Whole-Genome Analysis of Sporadic Amyotrophic Lateral SclerosisNew England Journal of Medicine, 2007
- Amyotrophic lateral sclerosisThe Lancet, 2007
- A High-Density Whole-Genome Association Study Reveals That APOE Is the Major Susceptibility Gene for Sporadic Late-Onset Alzheimer's DiseaseThe Journal of Clinical Psychiatry, 2007
- Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of dataThe Lancet Neurology, 2007
- Is decreased dexterity in Parkinson disease due to apraxia?Neurology, 2007
- Molecular biology of amyotrophic lateral sclerosis: insights from geneticsNature Reviews Neuroscience, 2006
- Minocycline delays disease onset and mortality in a transgenic model of ALSNeuroReport, 2002